Hairon, Nerys, NICE · Nursing times · 2007
This document provides official guidance from NICE (the UK's health authority) on how doctors should manage ME/CFS. It offers recommendations for diagnosing the condition, treating symptoms, and supporting patients in their daily lives. The guidance is based on the best evidence available and aims to help healthcare providers give consistent, appropriate care to people with ME/CFS.
NICE guidelines significantly influence clinical practice throughout the UK and internationally, shaping how doctors diagnose and treat ME/CFS patients. Standardized guidance helps ensure patients receive consistent care and access to evidence-based management strategies, which is critical for a complex condition that is often poorly understood or managed in general practice.
This guideline does not test any new treatments or prove efficacy of specific interventions through clinical trials. It represents a summary and interpretation of existing evidence rather than original research, and recommendations are only as strong as the underlying evidence base available at the time (2007). The guideline does not establish what causes ME/CFS or identify new biomarkers.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →